Delivery Order SPE2DB22D3004-SPE2DB25FSH04
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Phenobarbital 65 mg/ml vials, with a ceiling value of $4,516.61 and an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Phenobarbital 65 mg/mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,018.74 and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $4,494.60 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/ml vials, with an ultimate completion date of April 8, 2025. This firm fixed price delivery order, awarded on April 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,470.98 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/ml vials. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's existing federal contract portfolio and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $6,052.44. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $3,285.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Phenobarbital 130 mg/ml vials. The contract represents a non-set-aside competitive award with an ultimate completion date of August 29, 2025, and performance location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Phenobarbital 65 mg/mL vials with a ceiling value of $1,133.18. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,488 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Phenobarbital 130 mg/mL vials. This competitively awarded, firm fixed-price contract is not set aside for any specific business category and is scheduled for completion by July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,019.16 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This non-set-aside, competitively awarded contract employs firm fixed pricing and was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.75 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 130 mg/mL vials. This firm fixed-price, competitively awarded contract contains no set-aside designation and is scheduled for completion by July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a routine pharmaceutical procurement supporting federal...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH04Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Phenobarbital 130 mg/mL vials valued at $3,106.84. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 5, 2025, with the place of performance located in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor for federal medical procurement, specifically supporting military and defense healthcare supply chains. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates consistent success in competitive procurement processes, with the company serving as a major pharmaceutical distributor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/4/25 |